InvestorsHub Logo
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Re: doingmybest post# 97470

Sunday, 01/22/2017 11:27:24 AM

Sunday, January 22, 2017 11:27:24 AM

Post# of 701121
Makes sense to me. I had long wondered if in spite of being the most dangerous tumors, the mesenchymals had limited Checkpoint/Blockade function (having some other very nasty features that more than compensate). That DCVax-L works well on Mesenchymal, in spite of it being the most dangerous tumor, because of this weak checkpoint function. And I thought I recently saw something posted that aligned with that.

If so, and if DCVax-L were to be approved for all GBM, then the logical therapy after progression would be DCVax-L + CI.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News